Chinese Alliance for Type 1 Diabetes Multi-center Collaborative Research

Recruiting now

Conditions studied: Type 1 Diabetes Mellitus

In brief

The China Alliance for Type 1 Diabetes (CAT1D) is committed to exploring and implementing the model of graded diagnosis and treatment of type 1 diabetes and comprehensive management of outpatient service, carrying out a series of educational activities for patients, and cooperating in the development of multi-center prospective clinical research on type 1 diabetes.

Key facts

Study ID

NCT04096794

Run by

Second Xiangya Hospital of Central South University

People needed

500

Starts

2016-09-01

Expected to finish

2027-09-01

Last updated by the study team

2023-04-21

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Individuals diagnosed with Type 1 Diabetes according to the 1999 World Health Organization report
• Written informed consent from the patient or family representative;
• Individuals who own smartphone and are capable of using wechat or apps

You may not qualify if…

• Non-t1dm patients with autoimmune polyendocrine adenopathy syndrome (APS) are the first disease
• With mental disorders
• Have any other condition or disease that may hamper from compliance with the protocol or complication of the trial

Where it is running

• Institute of Metabolism and Endocrinology, Second Xiangya Hospital, Central South University — Changsha, Hunan, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.